Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple...

Area of Science:

• Neuroimmunology
• Immunology
• Clinical Medicine

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS).
• Understanding the differences between systemic and CNS immunity is crucial for managing MS exacerbations.
• Immune responses in the blood and CSF may differ significantly during active MS.

Purpose of the Study:

• To elucidate differences in systemic and CNS immunity relevant to multiple sclerosis (MS) relapses.
• To compare immune cell profiles in peripheral blood and cerebrospinal fluid (CSF) of patients with relapsing-remitting MS (RRMS).

Main Methods:

• Simultaneous analysis of paired peripheral blood and CSF samples from 36 non-treated RRMS patients.
• Flow cytometry was used to determine percentages of functional lymphocyte subsets.
• Enzyme-linked immunosorbent assays (ELISAs) measured soluble immune mediators.

Main Results:

• Active RRMS patients showed increased CD4+ CXCR3+ Th1 cells in blood, inversely correlated with IL-10 and IL-12p70.
• CSF of active RRMS patients had increased CD4+ CD25+ cells and decreased CD8+ CD11a(high) cells.
• CSF CD4+ CD25+ cells correlated with CSF inflammation markers (leukocytes, albumin, CXCL10).
• CSF CD8+ CD11a(high) cells correlated with CSF IL-4, suggesting an immunoregulatory role.

Conclusions:

• MS relapses are associated with altered cell-mediated immunity differing between blood and CSF compartments.
• Specific lymphocyte subsets in CSF, like CD4+ CD25+ and CD8+ CD11a(high) cells, may serve as biomarkers for CNS inflammation and regulation.
• Monitoring lymphocyte subsets could aid in assessing MS disease status.